loader
Please Wait
Applying Filters...

List of All Manufacturers & Suppliers of Eribulin Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
$ API Ref.Price (USD/KG) : 14,161,255Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Dr. Reddy\'s Laboratories

02 1Clinigen Group

03 5Eisai

04 5Eisai Inc

05 1GLAND PHARMA LIMITED

06 1JIANGXI QINGFENG

07 1Long Grove Pharmaceuticals

08 1Natco Pharma (Canada) Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Eribulin

Brand Name :

Dosage Form : Injection

Dosage Strength : 0.5MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Dr Reddy Company Banner

02

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Eribulin Mesilate

Brand Name : Halaven

Dosage Form : INJ

Dosage Strength : 100mg/ 5 ml

Packaging : 2X1mg/2ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

03

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Eribulini mesilas

Brand Name : Halaven

Dosage Form : Inj Solution

Dosage Strength : 1mg/2ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

eribulin

Brand Name : Halaven

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

05

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

eribulin

Brand Name : Halaven

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

06

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

eribulin

Brand Name : Halaven

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

07

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

eribulin

Brand Name : Halaven

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

08

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

ERIBULIN MESYLATE

Brand Name : HALAVEN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1MG/2ML (0.5MG/ML)

Packaging :

Approval Date : 2010-11-15

Application Number : 201532

Regulatory Info : RX

Registration Country : USA

blank

09

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

eribulinmesilat

Brand Name : HALAVEN

Dosage Form : SOLUTION FOR INJECTION

Dosage Strength : 0.44 MG / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

10

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Eribulin

Brand Name : Halaven

Dosage Form : Eribulina 0.88Mg 2Ml 1 Units Parenteral Use

Dosage Strength : 1 vial EV 0.88 mg 2 ml 0.44 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

11

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Eribulin

Brand Name : Halaven

Dosage Form : Injection fluid, resolution

Dosage Strength : 0.44 mg/ml

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

12

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

ERIBULIN MESYLATE

Brand Name : HALAVEN

Dosage Form : SOLUTION

Dosage Strength : 0.5MG/ML

Packaging : 2ML

Approval Date :

Application Number : 2377438

Regulatory Info : Prescription

Registration Country : Canada

blank

13

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

ERIBULIN MESYLATE

Brand Name : ERIBULIN MESYLATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1MG/2ML (0.5MG/ML)

Packaging :

Approval Date : 2024-04-05

Application Number : 218047

Regulatory Info : RX

Registration Country : USA

blank

14

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

ERIBULIN MESYLATE

Brand Name : ERIBULIN MESYLATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1MG/2ML (0.5MG/ML)

Packaging :

Approval Date : 2024-07-18

Application Number : 214850

Regulatory Info : RX

Registration Country : USA

blank

15

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

ERIBULIN MESYLATE

Brand Name : NAT-ERIBULIN

Dosage Form : SOLUTION

Dosage Strength : 0.5MG/ML

Packaging :

Approval Date :

Application Number : 2539136

Regulatory Info : Prescription

Registration Country : Canada

blank

16

JIANGXI QINGFENG

Country
Discovery on Target
Not Confirmed
arrow

JIANGXI QINGFENG

Country
arrow
Discovery on Target
Not Confirmed

ERIBULIN MESYLATE

Brand Name : ERIBULIN MESYLATE

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1MG/2ML (0.5MG/ML)

Packaging :

Approval Date : 2024-06-28

Application Number : 218281

Regulatory Info : RX

Registration Country : USA

blank